GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (FRA:PFEB) » Definitions » Cyclically Adjusted PS Ratio

Pfizer (FRA:PFEB) Cyclically Adjusted PS Ratio : 2.55 (As of Jun. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pfizer Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Pfizer's current share price is €9.20. Pfizer's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €3.61. Pfizer's Cyclically Adjusted PS Ratio for today is 2.55.

The historical rank and industry rank for Pfizer's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:PFEB' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.22   Med: 4.04   Max: 6.59
Current: 2.5

During the past years, Pfizer's highest Cyclically Adjusted PS Ratio was 6.59. The lowest was 2.22. And the median was 4.04.

FRA:PFEB's Cyclically Adjusted PS Ratio is ranked worse than
57.2% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs FRA:PFEB: 2.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pfizer's adjusted revenue per share data for the three months ended in Mar. 2024 was €2.403. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €3.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pfizer's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted PS Ratio Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.41 4.43 6.29 4.74 2.57

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 3.28 2.94 2.57 2.42

Competitive Comparison of Pfizer's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PS Ratio falls into.



Pfizer Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pfizer's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9.20/3.61
=2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pfizer's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.403/131.7762*131.7762
=2.403

Current CPI (Mar. 2024) = 131.7762.

Pfizer Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.459 100.560 1.912
201409 1.498 100.428 1.966
201412 1.669 99.070 2.220
201503 1.595 99.621 2.110
201506 1.692 100.684 2.215
201509 1.725 100.392 2.264
201512 2.063 99.792 2.724
201603 1.876 100.470 2.461
201606 1.903 101.688 2.466
201609 1.890 101.861 2.445
201612 2.114 101.863 2.735
201703 1.961 102.862 2.512
201706 1.901 103.349 2.424
201709 1.829 104.136 2.314
201712 1.910 104.011 2.420
201803 1.728 105.290 2.163
201806 1.937 106.317 2.401
201809 1.904 106.507 2.356
201812 0.172 105.998 0.214
201903 2.019 107.251 2.481
201906 2.070 108.070 2.524
201909 2.038 108.329 2.479
201912 0.295 108.420 0.359
202003 1.626 108.902 1.968
202006 1.559 108.767 1.889
202009 1.549 109.815 1.859
202012 1.659 109.897 1.989
202103 2.154 111.754 2.540
202106 2.763 114.631 3.176
202109 3.569 115.734 4.064
202112 3.658 117.630 4.098
202203 4.047 121.301 4.396
202206 4.595 125.017 4.843
202209 3.999 125.227 4.208
202212 3.991 125.222 4.200
202303 3.015 127.348 3.120
202306 2.057 128.729 2.106
202309 2.196 129.860 2.228
202312 2.314 129.419 2.356
202403 2.403 131.776 2.403

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (FRA:PFEB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pfizer Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (FRA:PFEB) Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (FRA:PFEB) Headlines

No Headlines